|Last Price||Today's Change||52-Week Range||Trading Volume|
|14.72||-0.12 (-0.81%)||14.57 - 19.37||63.1 thousand (Above Avg)|
Market data as of 3:59PM 11/25/14. Quotes are delayed by at least 15 min.
Daiichi Sankyo and Ambit Announce Results of Tender Offer
11/10/2014 7:37 PM ET
U.S. FDA Cardiovascular and Renal Drugs Advisory Committee Makes Recommendation on Daiichi Sankyo's Once-Daily SAVAYSA™ (edoxaban) for the Reduction in Risk of Stroke and Systemic Embolic Events in Patients with Non-Valvular Atrial Fibrillation
10/30/2014 8:08 PM ET